2023
DOI: 10.1016/s2352-3018(23)00238-2
|View full text |Cite
|
Sign up to set email alerts
|

Post-exposure prophylaxis to prevent HIV: new drugs, new approaches, and more questions

Kenneth H Mayer,
Lao-Tzu Allan-Blitz
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 56 publications
0
0
0
Order By: Relevance
“…Co-formulated regimens using integrase strand transfer inhibitors are well tolerated [ 58 ] and may simplify medication delivery. New regimens are also under investigation including long-acting injectable therapies, topical gels, and vaginal inserts [ 59 ], which might facilitate improved access and adherence to therapy. Formulations that are required to be prescribed in their original packaging might also limit practical mechanisms of medication adherence support (eg, pill boxes); drug manufacturers should consider provision of drug stability data where applicable to permit such adherence aids.…”
Section: Future Directionsmentioning
confidence: 99%
“…Co-formulated regimens using integrase strand transfer inhibitors are well tolerated [ 58 ] and may simplify medication delivery. New regimens are also under investigation including long-acting injectable therapies, topical gels, and vaginal inserts [ 59 ], which might facilitate improved access and adherence to therapy. Formulations that are required to be prescribed in their original packaging might also limit practical mechanisms of medication adherence support (eg, pill boxes); drug manufacturers should consider provision of drug stability data where applicable to permit such adherence aids.…”
Section: Future Directionsmentioning
confidence: 99%